Fulcrum Therapeutics, Inc. (FULC) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$7.59
Day's range
$8.12

Fulcrum Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 8.82 M $32.30 M   63.70% 11.57%
ECOR1 CAPITAL, LLC 08/14/2026 6.55 M $23.97 M   100.00% 8.59%
TANG CAPITAL MANAGEMENT LLC 08/14/2026 6.52 M $23.87 M   100.00% 8.55%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 5.48 M $20.04 M   79.51% 7.18%
SUVRETTA CAPITAL MANAGEMENT, LLC 08/14/2026 3.68 M $13.47 M   -43.90% 4.83%
D. E. SHAW & CO., INC. 08/14/2026 3.04 M $11.14 M   87.55% 3.99%
CITADEL ADVISORS LLC 09/02/2026 2.70 M $9.90 M   109.25% 3.55%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.70 M $9.87 M   0.16% 3.54%
JANE STREET GROUP, LLC 08/14/2026 2.22 M $8.12 M   614.36% 2.91%
STATE STREET CORP 09/22/2026 2.04 M $7.46 M   31.43% 2.67%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 2.00 M $7.32 M   400.00% 2.62%
GSK PLC 08/13/2026 1.79 M $6.54 M   0.00% 2.34%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 1.75 M $6.40 M   79.38% 2.29%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 1.65 M $6.03 M   12,016.18% 2.16%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 1.57 M $5.73 M   1,098.70% 2.05%
MILLENNIUM MANAGEMENT LLC 08/14/2026 1.49 M $5.44 M   316.81% 1.95%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.43 M $5.24 M   -3.66% 1.88%
MARSHALL WACE, LLP 08/13/2026 1.36 M $4.97 M   100.00% 1.78%
UBS GROUP AG 08/13/2026 1.25 M $4.59 M   297.83% 1.64%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 1.18 M $4.32 M   1,065.38% 1.55%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 1.10 M $4.04 M   103.12% 1.45%
GOLDMAN SACHS GROUP INC 08/14/2026 1.09 M $4.01 M   91.36% 1.44%
IKARIAN CAPITAL, LLC 08/14/2026 1.05 M $3.84 M   0.00% 1.38%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.04 M $3.82 M   724.14% 1.37%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 1.04 M $3.79 M   42.83% 1.36%
JUMP FINANCIAL, LLC 08/13/2026 1.01 M $3.68 M   171.76% 1.32%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 960.55 K $3.52 M   -15.02% 1.26%
ASSENAGON ASSET MANAGEMENT S.A. 08/21/2026 835.20 K $3.06 M   -30.04% 1.10%
TWO SIGMA INVESTMENTS, LP 08/14/2026 812.77 K $2.97 M   484.72% 1.07%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 782.14 K $2.86 M   30.49% 1.03%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 745.32 K $2.73 M   1.17% 0.98%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 692.37 K $2.53 M   -61.10% 0.91%
Y-INTERCEPT (HONG KONG) LTD 07/14/2026 681.83 K $2.50 M   344.64% 0.89%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 651.43 K $2.38 M   -68.60% 0.85%
NORTHERN TRUST CORP 08/13/2026 487.87 K $1.79 M   3.15% 0.64%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 433.22 K $1.59 M   1.49% 0.57%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 433.22 K $1.59 M   100.00% 0.57%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 345.65 K $1.27 M   4.78% 0.45%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 303.99 K $1.11 M   0.00% 0.40%
BESSEMER GROUP INC 08/12/2026 286.99 K $1.05 M   0.00% 0.38%
PEAPOD LANE CAPITAL LLC 07/27/2026 285.80 K $1.05 M   100.00% 0.37%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 285.08 K $1.04 M   140.37% 0.37%
ENGINEERS GATE MANAGER LP 08/14/2026 242.00 K $885.72 K   91.90% 0.32%
HENNION & WALSH ASSET MANAGEMENT, INC. 07/08/2026 233.85 K $855.90 K   100.00% 0.31%
ENTRYPOINT CAPITAL, LLC 08/13/2026 217.20 K $794.95 K   380.02% 0.28%
XTX TOPCO LTD 08/14/2026 209.25 K $765.84 K   192.23% 0.27%
CITADEL ADVISORS LLC 09/02/2026 203.20 K $743.71 K   446.24% 0.27%
QUADRATURE CAPITAL LTD 08/07/2026 189.12 K $692.18 K   100.00% 0.25%
MORGAN STANLEY 08/13/2026 184.19 K $674.14 K   6.26% 0.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 175.40 K $641.96 K   109.56% 0.23%

Fulcrum Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 218 institutional investors and hedge funds held shares of Fulcrum Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 8.82 M

EcoR1 Capital, LLC: 6.55 M

TANG CAPITAL MANAGEMENT LLC: 6.52 M

Nantahala Capital Management, LLC: 5.48 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 3.68 M

D. E. Shaw & Co., Inc.: 3.04 M

104.80% of Fulcrum Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 88.93 M shares in the last 24 months. This purchase volume represents approximately $706.09 M in transactions.